+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Procainamide"

Atrial Fibrillation - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
From
From
From
From
From
2020 NAPA/Procainamide Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 NAPA/Procainamide Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Procainamide is a medication used to treat irregular heartbeats and other cardiac arrhythmias. It is a type of antiarrhythmic drug, and is classified as a Class Ia antiarrhythmic agent. It works by blocking sodium channels in the heart, which helps to regulate the heart rate. It is also used to treat ventricular tachycardia, a condition in which the heart beats too quickly. Procainamide is available in both oral and intravenous forms. It is typically used in combination with other medications, such as beta blockers and diuretics. It is generally well tolerated, but can cause side effects such as nausea, dizziness, and headache. Procainamide is a commonly used medication in the cardiovascular drug market. It is used to treat a variety of cardiac arrhythmias, and is generally well tolerated. It is available in both oral and intravenous forms, and is often used in combination with other medications. Some companies that produce procainamide include Pfizer, Merck, and Sanofi. Show Less Read more